Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Oct 25:12:159.
doi: 10.1186/s12955-014-0159-3.

When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer

Randomized Controlled Trial

When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer

Meghan L Underhill et al. Health Qual Life Outcomes. .

Abstract

Purpose: Evaluate baseline factors that may explain the influence of study site on decisional conflict (DC) in men from the Personal Patient Profile: Prostate (P3P) randomized trial.

Materials and methods: 476 cases from 5 P3P sites were included. Participants completed baseline demographic assessments, 4 subscales of the DC scale at baseline (uncertainty, informed, values clarity, and support), the Expanded Prostate Cancer Index Composite (short form) and the State-Trait Anxiety Inventory. Site data regarding typical practices were collected. Linear regressions were used to model the relation between baseline DC scores and study site adjusting for the list of variables.

Results: Baseline decisional uncertainly (p = 0.001) and informed (p = 0.03) subscales were significantly different across sites. Participant demographic and baseline measures were significantly different (p < 0.05) between sites except for trait anxiety. We identified participant level factors that explained study site differences at baseline for the decisional uncertainty and values clarity subscales: a preferred treatment choice at study entry, whether the study program was accessed at home vs. in clinic, number of doctors consulted pre-study, working status, state anxiety, information from the media or a health care provider, and perceived knowledge level. State anxiety was associated with higher DC across all subscales.

Conclusions: Individual characteristics of men seeking consultation for LPC were associated with DC at baseline, not the site alone; anxiety contributed to higher conflict. These findings will inform future development and implementation of the P3P and other decision support interventions.

Trial registration: NCT00692653.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean scores together with 95% confidence interval (CI) describing the variation in the four DCS subscales measured at baseline across sites. *Note: Higher mean scores indicate more Decisional Conflict; ANOVA testing mean difference across sites: Uncertainty subscale p<0.001; Informed subscale p = 0.03; values clarity subscale p = 0.12; support subscale p = 0.07.

References

    1. American Cancer Society . Cancer Facts and Figures 2014. Atlanta: American Cancer Society; 2014.
    1. Berry DL, Ellis WJ, Russell KJ, Blasko JC, Bush N, Blumenstein B, Lange PH. Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer. Clin Genitourin Cancer. 2006;5:219. doi: 10.3816/CGC.2006.n.040. - DOI - PubMed
    1. Sommers BD, Beard CJ, D’Amico AV, Kaplan I, Richie JP, Zeckhauser RJ. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer. 2008;113:2058. doi: 10.1002/cncr.23807. - DOI - PubMed
    1. Davison BJ, Breckon E. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns. 2012;87:369. doi: 10.1016/j.pec.2011.11.009. - DOI - PubMed
    1. Holmboe ES, Concato J. Treatment decisions for localized prostate cancer. J Gen Intern Med. 2000;15:694. doi: 10.1046/j.1525-1497.2000.90842.x. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data